Evidence map›Paper›PMID 26194615›Full record

ArticleNeurotoxicity research2015

Cognitive Impairment After Sleep Deprivation Rescued by Transcranial Magnetic Stimulation Application in Octodon degus.

C Estrada, D López, A Conesa, F J Fernández-Gómez, A Gonzalez-Cuello, F Toledo, I Tunez, O Blin, R Bordet, J C Richardson and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Neurotoxicity research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

C EstradaClinical & Experimental Neuroscience, Institute of Biomedical Research of Murcia (IMIB), School of Medicine, University of Murcia, Campus Mare Nostrum, 30100, Murcia, Spain.
D LópezClinical & Experimental Neuroscience, Institute of Biomedical Research of Murcia (IMIB), School of Medicine, University of Murcia, Campus Mare Nostrum, 30100, Murcia, Spain.
A ConesaClinical & Experimental Neuroscience, Institute of Biomedical Research of Murcia (IMIB), School of Medicine, University of Murcia, Campus Mare Nostrum, 30100, Murcia, Spain.
F J Fernández-GómezClinical & Experimental Neuroscience, Institute of Biomedical Research of Murcia (IMIB), School of Medicine, University of Murcia, Campus Mare Nostrum, 30100, Murcia, Spain.
A Gonzalez-CuelloClinical & Experimental Neuroscience, Institute of Biomedical Research of Murcia (IMIB), School of Medicine, University of Murcia, Campus Mare Nostrum, 30100, Murcia, Spain.
F ToledoClinical & Experimental Neuroscience, Institute of Biomedical Research of Murcia (IMIB), School of Medicine, University of Murcia, Campus Mare Nostrum, 30100, Murcia, Spain.
I TunezResearch Network on Ageing and Fragile (RETICEF), Department of Biochemistry and Molecular Biology, Faculty of Medicine, Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba University, Córdoba, Spain.
O BlinDepartment of Pharmacology, Aix-Marseille University, Marseille, France.
R BordetDepartment of Medical Pharmacology, University Lille-North, 1 Place Verdun, 59045, Lille, France.
J C RichardsonGlaxoSmithKline R&D, Neurosciences Therapeutic Area, Gunnels Wood Road, Stevenage, Herts, Sg1 2ny, UK.
E Fernandez-VillalbaClinical & Experimental Neuroscience, Institute of Biomedical Research of Murcia (IMIB), School of Medicine, University of Murcia, Campus Mare Nostrum, 30100, Murcia, Spain.
M T HerreroClinical & Experimental Neuroscience, Institute of Biomedical Research of Murcia (IMIB), School of Medicine, University of Murcia, Campus Mare Nostrum, 30100, Murcia, Spain. mtherrer@um.es.
Universidad de Murcia · ESAix-Marseille Université · FRGlaxoSmithKline (United Kingdom) · GBInstituto Maimónides de Investigación Biomédica de Córdoba · ESUniversité de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sleep is indispensable for maintaining regular daily life activities and is of fundamental physiological importance for cognitive performance. Sleep deprivation (SD) may affect learning capacity and the ability to form new memories, particularly with regard to hippocampus-dependent tasks. Transcranial magnetic stimulation (TMS) is a non-invasive procedure of electromagnetic induction that generates electric currents, activating nearby nerve cells in the stimulated cortical area. Several studies have looked into the potential therapeutic use of TMS. The present study was designed to evaluate how TMS could improve learning and memory functions following SD in Octodon degus. Thirty juvenile (18 months old) females were divided into three groups (control, acute, and chronic TMS treatment-with and without SD). TMS-treated groups were placed in plastic cylindrical cages designed to keep them immobile, while receiving head magnetic stimulation. SD was achieved by gently handling the animals to keep them awake during the night. Behavioral tests included radial arm maze (RAM), Barnes maze (BM), and novel object recognition. When TMS treatment was applied over several days, there was significant improvement of cognitive performance after SD, with no side effects. A single TMS session reduced the number of errors for the RAM test and improved latency and reduced errors for the BM test, which both evaluate spatial memory. Moreover, chronic TMS treatment brings about a significant improvement in both spatial and working memories.

Indexed as

Transcranial Magnetic StimulationAnimalsBrainCognition DisordersFemaleLearningMemoryOctodonRecognition, PsychologySleep DeprivationLearningMemoryOctodon degusSleep deprivationTranscranial magnetic stimulation (TMS)

Identifiers

PMID26194615
OpenAlexW1701058205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.